10x Genomics, Inc.
TXG
$26.88
-$0.64-2.33%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 183.98M | 153.64M | 146.82M | 134.29M | 156.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 183.98M | 153.64M | 146.82M | 134.29M | 156.23M |
| Cost of Revenue | 68.20M | 58.12M | 47.21M | 35.90M | 36.53M |
| Gross Profit | 115.78M | 95.53M | 99.61M | 98.39M | 119.71M |
| SG&A Expenses | 81.61M | 82.42M | 91.51M | 83.28M | 76.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 212.97M | 207.04M | 210.18M | 186.27M | 175.13M |
| Operating Income | -29.00M | -53.39M | -63.36M | -51.99M | -18.90M |
| Income Before Tax | -46.60M | -91.74M | -60.77M | -49.65M | -16.41M |
| Income Tax Expenses | 2.35M | 1.24M | 1.65M | 1.09M | 804.00K |
| Earnings from Continuing Operations | -48.95M | -92.99M | -62.41M | -50.75M | -17.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.95M | -92.99M | -62.41M | -50.75M | -17.22M |
| EBIT | -29.00M | -53.39M | -63.36M | -51.99M | -18.90M |
| EBITDA | -19.28M | -44.02M | -53.42M | -45.51M | -12.38M |
| EPS Basic | -0.41 | -0.79 | -0.53 | -0.44 | -0.15 |
| Normalized Basic EPS | -0.11 | -0.27 | -0.33 | -0.26 | -0.07 |
| EPS Diluted | -0.41 | -0.79 | -0.53 | -0.44 | -0.15 |
| Normalized Diluted EPS | -0.11 | -0.27 | -0.33 | -0.26 | -0.07 |
| Average Basic Shares Outstanding | 118.57M | 117.73M | 116.71M | 115.62M | 114.76M |
| Average Diluted Shares Outstanding | 118.57M | 117.73M | 116.71M | 115.62M | 114.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
